Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars H Lindner

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Cancers|June 22, 2023
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)Luc M Berclaz, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
The Oncologist|December 2, 2017
Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert SurveyChristian Rothermundt, Galina F Fischer, Sebastian Bauer, et al.
Annals of Surgery|November 8, 2014
Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter studyMartin K Angele, Markus Albertsmeier, Niclas J Prix, et al.
Annals of Surgical Oncology|September 13, 2017
External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-AnalysisMarkus Albertsmeier, Alexandra Rauch, Falk Roeder, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2021
Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter studySylvie Bonvalot, Jay Wunder, Alessandro Gronchi, et al.
Cancers|April 3, 2021
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal CancerOliver J Ott, Cihan Gani, Lars H Lindner, et al.
International Journal of Cancer|March 3, 2016
Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repairDominique Harnicek, Eric Kampmann, Kirsten Lauber, et al.
Journal of Cancer Research and Clinical Oncology|August 5, 2023
Implementing precision oncology for sarcoma patients: the CCC<sup>LMU</sup>molecular tumor board experienceLuc M Berclaz, Anton Burkhard-Meier, Philipp Lange, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized TrialHeikki Joensuu, Eva Wardelmann, Mikael Eriksson, et al.
British Journal of Cancer|June 11, 2024
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trialHeikki Joensuu, Annette Reichardt, Mikael Eriksson, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Cancers|June 22, 2023
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)Luc M Berclaz, Annelore Altendorf-Hofmann, Lars H Lindner, et al.
The Oncologist|December 2, 2017
Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert SurveyChristian Rothermundt, Galina F Fischer, Sebastian Bauer, et al.
Annals of Surgery|November 8, 2014
Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter studyMartin K Angele, Markus Albertsmeier, Niclas J Prix, et al.
Annals of Surgical Oncology|September 13, 2017
External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-AnalysisMarkus Albertsmeier, Alexandra Rauch, Falk Roeder, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 7, 2021
Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter studySylvie Bonvalot, Jay Wunder, Alessandro Gronchi, et al.
Cancers|April 3, 2021
Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal CancerOliver J Ott, Cihan Gani, Lars H Lindner, et al.
International Journal of Cancer|March 3, 2016
Hyperthermia adds to trabectedin effectiveness and thermal enhancement is associated with BRCA2 degradation and impairment of DNA homologous recombination repairDominique Harnicek, Eric Kampmann, Kirsten Lauber, et al.
Journal of Cancer Research and Clinical Oncology|August 5, 2023
Implementing precision oncology for sarcoma patients: the CCC<sup>LMU</sup>molecular tumor board experienceLuc M Berclaz, Anton Burkhard-Meier, Philipp Lange, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2023
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized TrialHeikki Joensuu, Eva Wardelmann, Mikael Eriksson, et al.
British Journal of Cancer|June 11, 2024
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trialHeikki Joensuu, Annette Reichardt, Mikael Eriksson, et al.
Pageof 14